chr13-43883789-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_153218.4(LACC1):c.760A>G(p.Ile254Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 1,609,972 control chromosomes in the GnomAD database, including 48,467 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_153218.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LACC1 | NM_153218.4 | c.760A>G | p.Ile254Val | missense_variant | 4/7 | ENST00000325686.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LACC1 | ENST00000325686.7 | c.760A>G | p.Ile254Val | missense_variant | 4/7 | 1 | NM_153218.4 | P1 | |
LACC1 | ENST00000441843.5 | c.760A>G | p.Ile254Val | missense_variant | 4/7 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.269 AC: 40822AN: 151930Hom.: 5706 Cov.: 32
GnomAD3 exomes AF: 0.277 AC: 69444AN: 250572Hom.: 10215 AF XY: 0.274 AC XY: 37066AN XY: 135442
GnomAD4 exome AF: 0.236 AC: 343712AN: 1457924Hom.: 42753 Cov.: 31 AF XY: 0.238 AC XY: 172651AN XY: 725398
GnomAD4 genome AF: 0.269 AC: 40850AN: 152048Hom.: 5714 Cov.: 32 AF XY: 0.271 AC XY: 20149AN XY: 74328
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied by a panel of primary immunodeficiencies. Number of patients: 40. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Juvenile arthritis due to defect in LACC1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Leprosy, susceptibility to, 1 Other:1
Uncertain risk allele, no assertion criteria provided | case-control | Centro Dermatológico Federico Lleras Acosta, Hospital Universitario Centro Dermatológico Federico Lleras Acosta | Jun 10, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at